首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1454159

全球快速診斷市場規模、佔有率、成長分析、按產品、按平台、按最終用途 - 行業預測，2024-2031 年

Global Rapid Diagnostics Market Size, Share, Growth Analysis, By product, By platform, By End use, By Application - Industry Forecast 2024-2031

出版日期: 2024年03月11日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球快速診斷市場規模為292.6億美元，從2023年的353.9億美元成長到2031年的1620.8億美元，預測期間（2024-2031年）複合年成長率為20.95%。

快速診斷主要用於資源有限的醫療機構中醫療狀況的初步或緊急篩檢。操作簡單快捷，可在初級保健環境中進行即時檢測。多種傳統診斷方法結合了快速診斷方法，包括快速抗體測試（例如快速HIV測試）、快速血漿試劑和快速抗原測試（例如快速流感診斷、快速瘧疾抗原檢測測定）。快速診斷測試廣泛應用於篩檢、流行病學、患者管理和診斷。推動市場擴張的關鍵因素是對分散環境中快速診斷的需求不斷成長，以及公眾對早期診斷好處的認知不斷提高。此外，由於對價格實惠的準確診斷的需求不斷成長，預計市場將會擴大。然而，由於消費者對市場上可用的新型快速診斷缺乏認知，快速診斷市場的成長受到阻礙。也就是說，快速診斷市場預計將受益於床邊診斷需求的不斷成長。照護現場快速診斷市場涵蓋一系列測試工具，包括血糖監測套件、懷孕和不孕症測試套件、感染疾病測試套件、尿液測試套件、血液學測試套件、心臟代謝監測套件和類似工具。這些測試用於醫院、專科診所和私人家庭。照護現場和快速診斷領域的市場成長主要是由感染疾病的高發病率、政府支持政策以及 CLIA 豁免 POC 檢查數量的增加所推動的。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東/非洲
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2021年）
主要市場參與者所採取的策略
關鍵成功策略
近期市集活動
主要企業市場佔有率（2021年）

主要企業簡介

Abbott Laboratories
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
F. Hoffmann-La Roche Ltd.
ACON Laboratories, Inc.
Creative Diagnostics
Danaher Corporation
Thermo Fisher Scientific Inc.
BioMA（C）rieux SA
Alfa Scientific Designs, Inc.
BTNX Inc.
Meridian Bioscience, Inc.
and Trinity Biotech plc

簡介目錄

Product Code: SQMIG35A2152

Global Rapid Diagnostics Market size was valued at USD 29.26 billion in 2022 and is poised to grow from USD 35.39 billion in 2023 to USD 162.08 billion by 2031, at a CAGR of 20.95% during the forecast period (2024-2031).

Rapid diagnostic tests (RDTs) are primarily utilized for preliminary or urgent screening of medical conditions in healthcare facilities with limited resources. They enable point-of-care testing in primary care settings through simple and rapid operations. Various traditional diagnostic methods, including rapid antibody tests (e.g., rapid HIV test), rapid plasma reagin, and rapid antigen tests (e.g., rapid influenza diagnostic test and rapid malaria antigen detection assays), incorporate rapid diagnostics. RDTs find extensive use in screening, epidemiology, patient management, and diagnosis. The market expansion is primarily driven by the increased demand for quick diagnostic tests in decentralized settings and growing public awareness of the benefits of early diagnosis. Moreover, the market is expected to grow due to the rising demand for accurate diagnostic tests at affordable prices. However, the growth of the quick diagnostics market is hindered by consumer unawareness of newer rapid diagnostic tests available in the market. Nevertheless, the market for quick diagnostics is expected to benefit from the increasing demand for bedside diagnostic testing. The point-of-care rapid diagnostics market encompasses a range of testing tools, including glucose monitoring kits, pregnancy and fertility testing kits, infectious disease testing kits, urinalysis testing kits, haematological testing kits, cardiometabolic monitoring kits, and similar tools. These tests are utilized in hospitals, professional clinics, and private residences. Market growth in the point-of-care and rapid diagnostics sector is primarily driven by the high prevalence of infectious diseases, supportive government policies, and an increasing number of CLIA-waived POC tests.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Rapid Diagnostics Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Rapid Diagnostics Market Segmental Analysis

The Global Rapid diagnostics market is segmented on the basis of product, platform, end use, application, and region. By product, the market is segmented into kits and equipment. By platform, the market is segmented into Immunoassays, Molecular Detection and other platforms. By end use, the market is segmented into Hospitals & Clinics, Diagnostic Laboratories, Home Care/Self Testing, and Other End Users. By application, the market is segmented into Infectious Diseases Testing , Pregnancy & Fertility Testing, Cardiac Metabolism Testing, Cholesterol Testing, Tumor/Cancer Markers Testing, Blood Glucose Testing, Urinalysis, Hematology Testing, Other Tests. By Region, the market is segmented into North America, Europe, Asia-Pacific, Latin America, and MEA.

Drivers of the Global Rapid Diagnostics Market

The increasing prevalence of chronic illnesses such as diabetes, cardiovascular diseases, and various infectious diseases has become notably prominent. This rise in chronic illnesses is a key factor driving the demand for point-of-care diagnostics during the anticipated timeframe. Globally, the frequency of diabetes and other chronic diseases has seen a significant increase, resulting in a higher demand for quick point-of-care diagnostics to effectively treat these conditions. This trend is expected to contribute to favorable global market growth for point-of-care diagnostics.

Restraints in the Global Rapid Diagnostics Market

The lack of accuracy in rapid point-of-care diagnostic tests worldwide, coupled with the low number of FDA approvals for rapid testing, has hindered the growth of the entire industry due to the high cost associated with virus clearing technology. The field of point-of-care testing is susceptible to pre-analytical errors, which may limit the introduction of new products and impede market growth. For instance, Siemens Healthcare issued a Class 2 Device Recall for their BGEM Analyze Card In-vitro Diagnostic Device in August 2020 due to conflicting glucose results on card lot 01-20095-10. Such inconsistencies can delay the diagnosis of hyperglycemia or result in unnecessary hypoglycemia treatment. Consequently, during the projected period, the lack of precision in point-of-care testing is expected to restrict market expansion on a global scale.

Market Trends of the Global Rapid Diagnostics Market

Key market players are increasingly focusing on integrating cutting-edge technologies such as artificial intelligence to develop effective point-of-care diagnostics. Advancements in lab-on-a-chip platforms, wearable technology, and breakthroughs in smartphone-based technologies have led to significant enhancements in point-of-care testing (POCT) devices. The implementation of deep learning systems on the cloud has paved the way for upcoming disruptions. Additionally, advancements in novel biosensors, microfluidics, and chip technology miniaturization have propelled the development of new diagnostic systems. Lab-on-a-chip technology, particularly in the detection of infectious diseases, is a significant driver of POCT advancements. Various bioassays, including microbiological culture, enzyme-linked immunosorbent assays (ELISA), and polymerase chain reaction (PCR), can now be conducted at the point of care, thanks to lab-on-a-chip technology. As a result, the adoption of new technologies for manufacturing point-of-care testing kits is expected to bolster global market growth during the forecast period.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Rapid Diagnostics Market by product

Market Overview
kits and equipment

Global Rapid Diagnostics Market by platform

Market Overview
Immunoassays
Molecular Detection and other platform

Global Rapid Diagnostics Market by End use

Market Overview
Hospitals & Clinics
Diagnostic Laboratories
Home Care/Self Testing
and Other End Users

Global Rapid Diagnostics Market by Application

Market Overview
Infectious Diseases Testing
Pregnancy & Fertility Testing
Cardiac Metabolism Testing
Cholesterol Testing
Tumour/Cancer Markers Testing
Blood Glucose Testing
Urinalysis
Hematology Testing
Other Tests

Global Rapid Diagnostics Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ACON Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Creative Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioMA(C)rieux S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alfa Scientific Designs, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BTNX Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meridian Bioscience, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
and Trinity Biotech plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments